Publication date: Aug 12, 2019
Kristi Rosa reports on an FDA approval in tenosynovial giant cell tumor, a breakthrough therapy designation in melanoma, encouraging findings in trials in bladder cancer, lung cancer, and a cell-free DNA assay.
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Melanoma |
| disease | DOID | Melanoma |
| pathway | BSID | Melanoma |
| disease | MESH | tenosynovial giant cell tumor |
| disease | DOID | tenosynovial giant cell tumor |
| disease | MESH | bladder cancer |
| disease | DOID | bladder cancer |
| pathway | BSID | Bladder Cancer |
| pathway | BSID | Bladder cancer |
| disease | MESH | lung cancer |
| disease | DOID | lung cancer |